バイオチップ(DNAバイオチップ、プロテインバイオチップ、ラボオンチップ、その他)の世界市場

◆英語タイトル:Biochips (DNA Biochips, Protein Biochips, Lab-on-a-Chip, etc.) : Global Strategic Business Report
◆商品コード:GIA60107
◆発行会社(調査会社):Global Industry Analysts
◆発行日:2016年2月
◆ページ数:292
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single User(DRM付き)USD4,950 ⇒換算¥549,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobal Industry Analysts社の日本における正規販売代理店です。Global Industry Analysts社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、バイオチップ(DNAバイオチップ、プロテインバイオチップ、ラボオンチップ、その他)の世界市場について調査・分析し、バイオチップ(DNAバイオチップ、プロテインバイオチップ、ラボオンチップ、その他)の世界市場規模、市場動向、市場予測、関連企業情報などをお届けいたします。
【レポートの概要】

This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others. The report further analyzes the market by the following Applications: Research, Diagnostics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as –
Affymetrix, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Cepheid Inc.
Fluidigm Corporation

【レポートの目次】

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
A. DNA Biochips
B. Protein Biochips
C. Lab-on-a-Chip
D. Others
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
Biochips – A Primer
Expanding Application Areas
Current & Future Analysis
DNA Biochips Lead the Application Front
Protein Biochips – Set for Robust Expansion
Lab-on-a-Chip: Fusion of Nanotechnology & Genetic Engineering
Key Applications of Lab-on-a-Chip Technology
Molecular Biology and Lab-On-A-Chip
Proteomics and Lab-On-A-Chip
Cell Biology and Lab-On-A-Chip
Chemistry and Lab-On-A-Chip
Growth Drivers/Market Trends
Proteomics and Genomics Drive Demand for Biochips
Growing Preference for DNA/Protein Biochips in Personalized Medicine
Application of Biochips in Drug Discovery – A Strong Growth Driver
Cancer: An Important Driver for the Biochips Market
Table 1: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart)
Table 2: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal, and Liver Cancers (includes corresponding Graph/Chart)
Table 3: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus, and Liver Cancers (includes corresponding Graph/Chart)
Increasing Prevalence of Lifestyle Diseases Boost Diagnostic Microarray Market
Table 4: Global Diabetes Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart)
Table 5: Percentage Increase in DM Incidence among Ages 20-79 Worldwide by Geographic Region: 2013-2035 (includes corresponding Graph/Chart)
Government Efforts to Promote Biochip Technology
Integrating Tools with Diagnostic Capabilities with Smartphones – A Futuristic Trend
Microfluidic and Lab-on-a-chip Devices for Pharmacogenomics
Lab-on-a-Chip System for Better Pulmonary Disease Outcome
Industry Challenges
Standardization: A Key Challenge
High Costs Restrain Growth
Precise Protein Detection: A Challenge
2. INNOVATIONS IN THE BIOCHIPS INDUSTRY
Biochip Innovations in Drug Discovery Applications
HuRELflow
MetaChip and Subsequent Versions
Lab-on-a-Chip Devices in Smart Delivery of Drugs
Biochips from AYOXXA: A Giant Leap in Protein Multiplexing
Key Developments in the Past
3. COMPETITION
Industry Structure
Major Participants
Affymetrix: A Pioneer Player
Growing Partnerships between Pharma and Biotech Companies
Outsourcing: A Positive Trend
4. PRODUCT OVERVIEW
Biochips – Complex Blend of Biochemistry and Electronics
Historical Perspective
Promising Biochips Promote Biological Research
Lab-on-a-chip: An Enabled Technology
Utility
Evolution and Segmentation
Differing Perspectives
Classification of Biochips
Need for Biochips
Manufacturing Systems Used in Biochip Manufacture
Working of a Biochip
DNA Transcription & Translation through A Biochip
A Functional Model
Cocktail of Disparate Technically Specialized Applications
Biochips: By-product of Multi-disciplinary Sciences
Nanotechnology
BioMEMS
Microfluidics
Micro Total Analysis System
5. BIOCHIP AND MICROARRAY CONSTRUCTION
Chip Architecture
Essence of a Biochip
Concept of a Microarray
Microarray Modules
High Degree of Automation Spurs Biochips Use
Microfabrication Technology in Biochips made from Polymer and Plastics
Micro-optics in Biochips
Liquid Handling Through Micro-Dispensers
Capillary Electrophoresis and Electrochemical Detectors
Other Technologies
Management of Bio-information
Scanning
Microarray Database Management
Classification of DNA Chips
General Description of Spotted cDNA Microarrays
Spotted DNA Arrays
Spotted cDNA Versus Spotted Oligonucleotide Arrays
Limitations of Conventional cDNA Microarrays
Protein Biochips
General Applications of Protein Biochips:
Challenges in the Design of a Protein Biochip
Limitations of Protein Chip Technology
Concluding Remarks for Protein Biochips
6. APPLICATIONS OF BIOCHIPS
Biochip Uses
Pharmaceutical Investigation
Medical Diagnostics
Advantages of Biosensor Chip Technology
Forensics
Transplantation Screening
Identity Testing
Water and Environmental Testing
Food Industry
7. PRODUCT INTRODUCTIONS
Veredus Laboratories and AVA Launch VereVet™ Lab-on-Chip Application
Eurofins Scientific Launches Analytical DNA Chip Technology
Agilent Technologies Introduces Updated SurePrint Microarrays
Agilent Technologies Launches GenetiSure Pre-Screen Microarray
Agilent Technologies Launches Updates to SurePrint miRNA Microarrays
Clontech Laboratories Launches DNA SMART ChIP-Seq Kit
PerkinElmer Launches LabChip® GX Touch Automated Electrophoresis Systems
Cancer Genetics Launches Urogenital Cancer Array UroGenRA
A STAR and Veredus Launch VereTrop™ Biochip
8. RECENT INDUSTRY ACTIVITY
Sengenics Acquires Oxford Gene Technology’s Protein Array Technology
Immucor Acquires Sentilus
SQI Diagnostics Expands Collaboration with Global Pharmaceutical Company
Agenix Enters into Cross-Licensing Agreement with Arrayjet Limited
CombiMatrix and Manhattan Labs Enter into Distribution Partnership
Sequenom and CombiMatrix Enter Into Collaboration Agreement
9. FOCUS ON SELECT GLOBAL PLAYERS
Affymetrix, Inc. (US)
Agilent Technologies, Inc. (US)
Bio-Rad Laboratories, Inc. (US)
Cepheid Inc. (US)
Fluidigm Corporation (US)
GE Healthcare Ltd. (UK)
Hoffman-La-Roche Ltd. (Switzerland)
Illumina, Inc. (US)
Ocimum Biosolutions Ltd. (India)
PerkinElmer, Inc. (US)
Takara Bio, Inc. (Japan)
Clontech Laboratories, Inc. (US)
Thermo Fisher Scientific Inc. (US)
1.. GLOBAL MARKET PERSPECTIVE
Table 6: World Recent Past, Current & Future Analysis for Biochips by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 7: World Historic Review for Biochips by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 8: World 14-Year Perspective for Biochips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 9: World Recent Past, Current & Future Analysis for DNA Biochips by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 10: World Historic Review for DNA Biochips by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 11: World 14-Year Perspective for DNA Biochips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 12: World Recent Past, Current & Future Analysis for Protein Biochips by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 13: World Historic Review for Protein Biochips by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 14: World 14-Year Perspective for Protein Biochips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 15: World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 16: World Historic Review for Lab-on-a-Chip by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 17: World 14-Year Perspective for Lab-on-a-Chip by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 18: World Recent Past, Current & Future Analysis for Other Biochips by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 19: World Historic Review for Other Biochips by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 20: World 14-Year Perspective for Other Biochips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 21: World Recent Past, Current & Future Analysis for Biochips by Application – Research, Diagnostics, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 22: World Historic Review for Biochips by Application – Research, Diagnostics, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 23: World 14-Year Perspective for Biochips by Application – Percentage Breakdown of Dollar Sales for Research, Diagnostics, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET
1. THE UNITED STATES
A. Market Analysis
United States: The Global Leader for Biochips
Rising Demand in Biotechnology and Life Science Research Applications
Lab-on-a-Chip: The Leading Segment
Rapid Growth for Protein Biochips
DNA Biochip Market
Growth Drivers
Demand for Personalized Medicine Drives Market for Biochips
Aging Population: A Strong Demographic Driver
Table 24: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)
Table 25: The US Population Breakdown by Age Group (2014) (includes corresponding Graph/Chart)
Growing Incidence of Cancer & Lifestyle Disorders
Opportunity Indicators: Statistics Depicting Increasing Incidence of Cancer and Lifestyle Disorders
Table 26: The US Cancer Incidence by Gender (2014): No. of Reported New Cases for Men and Women (includes corresponding Graph/Chart)
Table 27: The US Cancer Incidence by Affected Site (2014): Number of New Cancer Cases (includes corresponding Graph/Chart)
Table 28: Prevalence of Diabetes Mellitus in the US (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group for the US (includes corresponding Graph/Chart)
Competition
Product Introductions
Strategic Corporate developments
Select Key Players
B. Market Analytics
Table 29: The US Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 30: The US Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 31: The US 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
2. CANADA
A. Market Analysis
Current & Future Analysis
Rising Incidence of Chronic Diseases Spurs Biochips Demand
Opportunity Indicators for Biochips Market:
Table 32: New Cancer Cases in Canada by Gender and Affected Site (2012) (includes corresponding Graph/Chart)
Table 33: New Cancer Cases in Canada by Province (2012) (includes corresponding Graph/Chart)
Table 34: Prevalence of Diabetes Mellitus in Canada (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group (includes corresponding Graph/Chart)
Strategic Corporate Development
B. Market Analytics
Table 35: Canadian Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 36: Canadian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 37: Canadian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
3. JAPAN
A. Market Analysis
Elderly Population Boosts the Biochip Market
Table 38: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)
B. Market Analytics
Table 39: Japanese Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 40: Japanese Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 41: Japanese 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4. EUROPE
A. Market Analysis
Current & Future Analysis
Leader in the DNA Biochip Segment
Lab-on-chip Market in Europe
European Advancements Shape Diagnostic Procedures
Ageing Population Boosts Demand
Table 42: European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart)
Opportunity Indicator for the Biochips Market: European Personalized Medicine Market Exhibits Robust Growth
Increasing Incidence of Cancer Drives Biochips Demand
Table 43: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
B. Market Analytics
Table 44: European Recent Past, Current & Future Analysis for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 45: European Historic Review for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 46: European 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 47: European Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 48: European Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 49: European 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4a. FRANCE
A. Market Analysis
Current & Future Analysis
Product Introduction
B. Market Analytics
Table 50: French Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 51: French Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 52: French 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4b. GERMANY
A. Market Analysis
Current & Future Analysis
Berlin, Brandenburg and Biochips
B. Market Analytics
Table 53: German Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 54: German Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 55: German 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4c. ITALY
A. Market Analysis
Current & Future Analysis
B. Market Analytics
Table 56: Italian Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 57: Italian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 58: Italian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A. Market Analysis
Current & Future Analysis
Strategic Corporate development
GE Healthcare Ltd. – A Key Player
B. Market Analytics
Table 59: UK Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 60: UK Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 61: UK 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4e. SPAIN
Market Analysis
Table 62: Spanish Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 63: Spanish Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 64: Spanish 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4f. RUSSIA
Market Analysis
Table 65: Russian Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 66: Russian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 67: Russian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
Market Analysis
Table 68: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 69: Rest of Europe Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 70: Rest of Europe 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A. Market Analysis
Increased Healthcare Spending Boosts the Biochips Market
India & China Offer Significant Growth Opportunities
Table 71: China and India Lead Global Population (July 2013): Table Depicting China and India’s Huge Population Vis-a-vis Other Countries’ Population (in Million) by Age Group (includes corresponding Graph/Chart)
Rising Diabetes Incidence in Asia-Pacific Offers Significant Growth Opportunities
Table 72: Prevalence of Diabetes Mellitus in South East Asia (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka
Table 73: Prevalence of Diabetes Mellitus in Western Asia-Pacific Regions (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
B. Market Analytics
Table 74: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 75: Asia-Pacific Historic Review for Biochips by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 76: Asia-Pacific 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for China, and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 77: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 78: Asia-Pacific Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 79: Asia-Pacific 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
5a. CHINA
A. Market Analysis
Basic Environment and Commercial Development
Biochip Research Institutes
Favorable Personalized Medicine Market Boosts Demand for Biochips
B. Market Analytics
Table 80: Chinese Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 81: Chinese Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 82: Chinese 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
5b. REST OF ASIA-PACIFIC
A. Market Analysis
India: Growing Investments in Pharmacogenomics Research Drives Biochips Market
Product Introductions
Strategic Corporate Development
Ocimum Biosolutions Ltd. – A Key India-based Player
B. Market Analytics
Table 83: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 84: Rest of Asia-Pacific Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 85: Rest of Asia-Pacific 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
6. LATIN AMERICA
Market Analysis
Table 86: Latin American Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 87: Latin American Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 88: Latin American 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
7. REST OF WORLD
Market Analysis
Table 89: Rest of World Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 90: Rest of World Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 91: Rest of World 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 79 (including Divisions/Subsidiaries - 86)
The United States (45)
Canada (2)
Japan (6)
Europe (22)
- France (2)
- Germany (6)
- The United Kingdom (3)
- Spain (2)
- Rest of Europe (9)
Asia-Pacific (Excluding Japan) (10)
Middle East (1)

★調査レポート[バイオチップ(DNAバイオチップ、プロテインバイオチップ、ラボオンチップ、その他)の世界市場]販売に関する免責事項
★調査レポート[バイオチップ(DNAバイオチップ、プロテインバイオチップ、ラボオンチップ、その他)の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆